Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank73
5Y CAGR-76.7%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
-76.7%/yr
Long-term compound
Percentile
P73
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 15.21% |
| 2024 | -14.61% |
| 2023 | 430.84% |
| 2022 | -73.08% |
| 2021 | -36.20% |
| 2020 | 22128.80% |
| 2019 | -99.32% |
| 2018 | 6.85% |
| 2017 | 103.53% |
| 2016 | 9.70% |